Aehr Test Sys SEC Filings

AEHR Test Systems reported an insider transaction by its Chief Operating Officer on a Form 4. On 10/13/2025, 385 shares of common stock were withheld at $25.52 under transaction code F to satisfy tax withholding obligations upon vesting of restricted stock units; this was not a sale by the reporting person.

Following the transaction, the officer beneficially owned 46,926 shares directly. The reported holdings include shares subject to unvested restricted stock units.

Aehr Test Systems director Danesh Fariba reported the sale of 9,000 shares of common stock on 10/09/2025, disclosed on a Form 4 filed under Section 16. The filing shows two sales: 2,665 shares at $24.87 and 6,335 shares at $24.755. After these transactions the form reports beneficial ownership levels of 22,978 and 16,643 shares (the latter figure includes unvested restricted stock units). The Form 4 was signed by an attorney-in-fact on 10/10/2025, indicating timely reporting of insider disposition activity.

Form 144 notice by an AEHR insider proposes sale of 6,335 common shares through Fidelity Brokerage Services with an aggregate market value of $156,823.56. The filing lists the approximate sale date as 10/09/2025 and shows 30,006,590 shares outstanding, so the proposed sale represents a small fraction of total equity.

The reported shares were acquired through recurring restricted stock vesting events between 01/27/2024 and 04/27/2025, totaling the 6,335 shares to be sold; there are no sales reported in the prior three months. The filer certifies no undisclosed material adverse information.

AEHR Test Systems (AEHR) reporting person Erickson Gayn, who serves as President, CEO and a director, reported a non‑derivative transaction dated 10/02/2025 where 439 shares of common stock were withheld to satisfy tax withholding on vested restricted stock units at a price of $32.25. After the withholding, the filing reports 269,153 shares directly beneficially owned and 291,628 shares indirectly beneficially owned through a trust, with the total reported position including unvested restricted stock units and restricted shares. The filing clarifies the withholding was not a sale by the reporting person and discloses the relationship to the issuer as Officer and Director.

AEHR (AEHR) filed a Form 144 notifying a proposed sale of 2,665 common shares, with an aggregate market value of $66,278, representing part of outstanding shares of 30,006,590. The shares are scheduled for sale on 10/09/2025 on NASDAQ. The filer acquired the shares on 04/18/2023 as compensation from the issuer and reports no sales in the prior three months. The notice includes the standard representation that the seller is unaware of undisclosed material adverse information.

AEHR Test Systems (AEHR) Form 4 shows an insider transaction dated 10/02/2025 by Alistair N. Sporck, listed as a company officer. The filing records 51 shares removed from his holdings under Code F at a price of $32.25; the filer explains these shares were withheld to satisfy tax withholding on vested restricted stock units rather than sold on the open market. After the withholding, the reporting person is shown as beneficially owning 29,904 shares directly and 5,214 shares indirectly through a trust, with some shares still subject to unvested restricted stock units. The form is signed by an attorney-in-fact on 10/08/2025.

AEHR Test Systems (AEHR) Form 4 shows insider activity by Alberto Salamone, who is reported as an executive (EVP, PPBI Business). On 10/02/2025 the filing records 406 shares reported as disposed at a price of $32.25. The filing explains those shares were withheld to satisfy tax withholding upon vesting of restricted stock units and therefore do not represent a sale by the reporting person. After the transaction the reporting person beneficially owned 77,979 shares, a total that the filing states includes shares subject to unvested restricted stock units.

AEHR Test Systems (AEHR) chief financial officer Chris Siu reported a withholding-related disposition of 126 shares of common stock on 10/02/2025 at a price of $32.25 per share; the filing states these shares were withheld to satisfy tax withholding obligations upon vesting of restricted stock units and do not represent a sale by the reporting person. After the withholding, the report shows 75,409 shares beneficially owned directly and 5,211 shares beneficially owned indirectly by a trust, with the reported direct total including shares subject to unvested restricted stock units.

AEHR TEST SYSTEMS insider filing shows an internal equity withholding tied to vesting of restricted stock units rather than an open-market sale. On 10/02/2025 the reporting person recorded a disposition coded F for 36 shares at a price of $32.25; the filer explains these shares were withheld to satisfy tax withholding obligations upon RSU vesting and "does not represent a sale." After the transaction the reporting person beneficially owned 69,426 shares, an amount the filer says includes unvested restricted stock units. The filing was signed by an attorney-in-fact on 10/08/2025.